Belite Bio Adr Stock Price Prediction

BLTE Stock  USD 63.26  4.18  6.20%   
The RSI of Belite Bio's share price is above 70 at the present time suggesting that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Belite, making its price go up or down.

Oversold Vs Overbought

75

 
Oversold
 
Overbought
The successful prediction of Belite Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Belite Bio and does not consider all of the tangible or intangible factors available from Belite Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Belite Bio ADR, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Belite Bio's stock price prediction:
EPS Estimate Next Quarter
(0.30)
EPS Estimate Current Year
(1.18)
EPS Estimate Next Year
(1.00)
Wall Street Target Price
79.25
EPS Estimate Current Quarter
(0.29)
Using Belite Bio hype-based prediction, you can estimate the value of Belite Bio ADR from the perspective of Belite Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Belite Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Belite because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Belite Bio after-hype prediction price

    
  USD 63.46  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Belite Bio Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Belite Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
45.2849.4769.59
Details
Naive
Forecast
LowNextHigh
48.4052.6056.79
Details
5 Analysts
Consensus
LowTargetHigh
40.9545.0049.95
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.29-0.29-0.29
Details

Belite Bio After-Hype Price Prediction Density Analysis

As far as predicting the price of Belite Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Belite Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Belite Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Belite Bio Estimiated After-Hype Price Volatility

In the context of predicting Belite Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Belite Bio's historical news coverage. Belite Bio's after-hype downside and upside margins for the prediction period are 59.27 and 67.65, respectively. We have considered Belite Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
63.26
63.46
After-hype Price
67.65
Upside
Belite Bio is very steady at this time. Analysis and calculation of next after-hype price of Belite Bio ADR is based on 3 months time horizon.

Belite Bio Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Belite Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Belite Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Belite Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.51 
4.19
  0.20 
  0.05 
7 Events / Month
14 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
63.26
63.46
0.32 
1,074  
Notes

Belite Bio Hype Timeline

Belite Bio ADR is currently traded for 63.26. The entity has historical hype elasticity of 0.2, and average elasticity to hype of competition of -0.05. Belite is anticipated to increase in value after the next headline, with the price projected to jump to 63.46 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.32%, whereas the daily expected return is currently at 0.51%. The volatility of related hype on Belite Bio is about 4579.23%, with the expected price after the next announcement by competition of 63.21. Net Loss for the year was (31.63 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days.
Check out Belite Bio Basic Forecasting Models to cross-verify your projections.

Belite Bio Related Hype Analysis

Having access to credible news sources related to Belite Bio's direct competition is more important than ever and may enhance your ability to predict Belite Bio's future price movements. Getting to know how Belite Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Belite Bio may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ANEBAnebulo Pharmaceuticals(0.02)5 per month 0.00 (0.02) 8.61 (11.48) 76.00 
MLYSMineralys Therapeutics, Common 0.14 8 per month 3.42  0  6.27 (5.79) 20.98 
ANTXAN2 Therapeutics 0.00 9 per month 1.69  0.12  6.00 (2.83) 28.03 
AVTEAerovate Therapeutics(0.02)3 per month 2.04  0.13  5.58 (3.86) 19.11 
ADAGAdagene(0.01)6 per month 0.00 (0.04) 8.13 (9.52) 37.93 
LRMRLarimar Therapeutics(0.49)9 per month 0.00 (0.06) 10.87 (9.55) 26.71 
IMRXImmuneering Corp 0.01 10 per month 5.15  0.12  15.50 (8.68) 60.06 
CNTACentessa Pharmaceuticals PLC(0.58)9 per month 3.08  0.09  8.37 (5.69) 21.09 
CELCCelcuity LLC(0.04)7 per month 0.00 (0.16) 4.55 (5.83) 16.97 
IKNAIkena Oncology(0.05)4 per month 0.00 (0.11) 1.81 (1.74) 5.87 
MOLNMolecular Partners AG(0.10)5 per month 4.92 (0.01) 9.38 (7.97) 52.92 
PMVPPmv Pharmaceuticals(0.1)3 per month 1.99 (0.03) 3.75 (3.64) 13.98 
GLUEMonte Rosa Therapeutics(0.74)8 per month 3.74  0.09  8.10 (8.18) 102.66 
TRDAEntrada Therapeutics 0.57 10 per month 2.84  0.07  6.14 (3.83) 18.81 
VIGLVigil Neuroscience 0.01 5 per month 0.00 (0.10) 7.39 (7.22) 37.50 
ACRVAcrivon Therapeutics, Common 0.1 6 per month 0.00 (0.08) 7.66 (7.65) 22.84 
ANABAnaptysBio(0.50)9 per month 0.00 (0.11) 5.77 (7.28) 35.57 
GLTOGalecto(0.38)5 per month 0.00 (0.25) 5.79 (8.62) 38.76 
AADIAadi Bioscience(0.03)5 per month 2.00  0.15  4.88 (3.80) 13.95 
ALGSAligos Therapeutics 0.40 11 per month 7.46  0.13  25.24 (11.21) 84.34 

Belite Bio Additional Predictive Modules

Most predictive techniques to examine Belite price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Belite using various technical indicators. When you analyze Belite charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Belite Bio Predictive Indicators

The successful prediction of Belite Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Belite Bio ADR, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Belite Bio based on analysis of Belite Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Belite Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Belite Bio's related companies.

Story Coverage note for Belite Bio

The number of cover stories for Belite Bio depends on current market conditions and Belite Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Belite Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Belite Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Belite Bio Short Properties

Belite Bio's future price predictability will typically decrease when Belite Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Belite Bio ADR often depends not only on the future outlook of the potential Belite Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Belite Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding26.6 M
Cash And Short Term Investments88.2 M

Complementary Tools for Belite Stock analysis

When running Belite Bio's price analysis, check to measure Belite Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Belite Bio is operating at the current time. Most of Belite Bio's value examination focuses on studying past and present price action to predict the probability of Belite Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Belite Bio's price. Additionally, you may evaluate how the addition of Belite Bio to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like